Pancreatic Acinar Cell Carcinoma: Demographics, Treatment, and Survival Outcomes, A Retrospective Population-Based Study
Journal of Gastrointestinal Cancer · 2025
DOI: 10.1007/s12029-025-01233-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal Cancer, 2025. Verfasst von Abdul Qahar Khan Yasinzai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of GI Oncology, University of Florida Health Cancer Center, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Carcinoma, Acinar Cell, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Pancreatic acinar cell carcinoma accounts for 1-2% of pancreatic tumors, with increasing frequency in recent years, and still represents a poor prognosis. This study aims to expand and update existing literature by analyzing national data gathered over almost two decades. METHODS: Data from 488 patients diagnosed with PACC in the Surveillance, Epidemiology, and End Results database were analyzed. This study employed the Cox regression method to compute hazard ratios and identify independent factors influencing survival. Additionally, Kaplan-Meier survival curves were utilized alongside the log-rank test. RESULTS: The median age was 64.7 years with male predilection (70.5%). "Poorly differentiated carcinoma" was the most common subtype (45.8%). The liver was the most common site of metastases (31.3%). The 5-year observed overall survival (OS) rate was 19.2% (95% CI, 14.9-23.8). The 5-year cause-specific survival (CSS) rate was 22.4% (95% CI, 17.7-27.5). Male gender has a 5-year OS of 19.2% (95% CI, 14.0-25.1) compared to female OS of 30.2% (95% CI, 20.7-40.1). Patients treated with multimodal therapy (surgery with chemoradiation) over only surgery or chemotherapy had better 5-year OS, 53.5% (95% CI, 31.8-71.0). Age > 60 and distant stage were independent factors associated with increased mortality. CONCLUSION: Pancreatic acinar cell carcinoma is a rare, aggressive form of pancreatic cancer that primarily affects older adults. Our findings offer valuable insights to guide future clinical guidelines and tailored treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of GI Oncology, University of Florida Health Cancer Center, Gainesville, FL, USA.
- Department of Hematology Oncology, University of Toledo, Toledo, OH, USA.
- Department of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4 Th Street, MS 9410, Lubbock, TX, 79430, USA. diego.bernal@ttuhsc.edu.
- Medical College of Georgia, Augusta, GA, USA.
- Banner University Medical Center, Phoenix, AZ, USA.
- University of Georgia, Athens, GA, USA.
Zitieren
APA
Yasinzai, A. Q. K., Iqbal, A., Olavarria-Bernal, D., Ballur, K., Wali, A., Ballur, S., Tareen, B., Khan, M., Jain, H., Khan, I., Fadhil, N., Sohail, A. H., & Ullah, A. (2025). Pancreatic Acinar Cell Carcinoma: Demographics, Treatment, and Survival Outcomes, A Retrospective Population-Based Study. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-025-01233-9
Vancouver
Yasinzai AQK, Iqbal A, Olavarria-Bernal D, Ballur K, Wali A, Ballur S, et al. Pancreatic Acinar Cell Carcinoma: Demographics, Treatment, and Survival Outcomes, A Retrospective Population-Based Study. Journal of Gastrointestinal Cancer. 2025. doi:10.1007/s12029-025-01233-9
BibTeX
@article{Yasinzai2025,
author = {Yasinzai, Abdul Qahar Khan and Iqbal, Asif and Olavarria-Bernal, Diego and Ballur, Kalyani and Wali, Agha and Ballur, Shalini and Tareen, Bisma and Khan, Marjan and Jain, Hritvik and Khan, Israr and Fadhil, Nooran and Sohail, Amir Humza and Ullah, Asad},
title = {Pancreatic Acinar Cell Carcinoma: Demographics, Treatment, and Survival Outcomes, A Retrospective Population-Based Study},
journal = {Journal of Gastrointestinal Cancer},
year = {2025},
doi = {10.1007/s12029-025-01233-9}
}
EUVIMED